1. Home
  2. VYGR vs CPS Comparison

VYGR vs CPS Comparison

Compare VYGR & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • CPS
  • Stock Information
  • Founded
  • VYGR 2013
  • CPS 1960
  • Country
  • VYGR United States
  • CPS United States
  • Employees
  • VYGR N/A
  • CPS N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • CPS Auto Parts:O.E.M.
  • Sector
  • VYGR Health Care
  • CPS Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • CPS Nasdaq
  • Market Cap
  • VYGR 342.5M
  • CPS 280.3M
  • IPO Year
  • VYGR 2015
  • CPS N/A
  • Fundamental
  • Price
  • VYGR $5.75
  • CPS $13.60
  • Analyst Decision
  • VYGR Strong Buy
  • CPS
  • Analyst Count
  • VYGR 9
  • CPS 0
  • Target Price
  • VYGR $16.44
  • CPS N/A
  • AVG Volume (30 Days)
  • VYGR 485.6K
  • CPS 159.9K
  • Earning Date
  • VYGR 11-12-2024
  • CPS 02-13-2025
  • Dividend Yield
  • VYGR N/A
  • CPS N/A
  • EPS Growth
  • VYGR N/A
  • CPS N/A
  • EPS
  • VYGR 0.47
  • CPS N/A
  • Revenue
  • VYGR $163,784,000.00
  • CPS $2,743,783,000.00
  • Revenue This Year
  • VYGR N/A
  • CPS N/A
  • Revenue Next Year
  • VYGR N/A
  • CPS $9.07
  • P/E Ratio
  • VYGR $12.33
  • CPS N/A
  • Revenue Growth
  • VYGR 3.40
  • CPS N/A
  • 52 Week Low
  • VYGR $5.19
  • CPS $11.24
  • 52 Week High
  • VYGR $11.72
  • CPS $20.82
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 41.30
  • CPS 40.29
  • Support Level
  • VYGR $6.08
  • CPS $14.59
  • Resistance Level
  • VYGR $6.55
  • CPS $15.50
  • Average True Range (ATR)
  • VYGR 0.35
  • CPS 0.87
  • MACD
  • VYGR -0.05
  • CPS -0.20
  • Stochastic Oscillator
  • VYGR 14.51
  • CPS 13.40

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.

Share on Social Networks: